Angola approves Russia's Sputnik Light one-dose vaccine
Developed by Moscow’s Gamaleya Institute, the slimmed-down vaccine, which the RDIF said is 79.4% effective against COVID-19 and costs under $10 a dose, has been earmarked for export and has been billed as a way to help vaccine supplies go further in countries with high infection rates.
In March 2021, the two-dose Sputnik V vaccine was also approved for use in Angola under the emergency use authorization procedure.
To date Sputnik V has been authorized in 64 countries with total population of over 3.2 billion people. ■